News

Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds
Trump’s planned pharmaceutical tariffs would raise costs by $51bn annually, report finds - Prices of medication and other ...
Drug costs could skyrocket by $51 billion annually with proposed tariffs, report finds
The report, not made public, was commissioned by the main US pharmaceutical lobby, the Pharmaceutical Research and ...
BizWest7h
For bioscientists facing funding cuts, tariffs: ‘It’s grim out there’
Perhaps no industry is as reliant on grant-funded university research as is bioscience, the companies that develop ...
Crain's Cleveland Business8h
Amgen pledges $900M, hundreds of jobs in Ohio expansion
Amgen Inc. will invest $900 million to expand an Ohio manufacturing facility, the latest drug company to promise increased US ...
Pharmaceutical tariffs: Which countries does the U.S. import the most from?
The United States has a $115.5 billion trade deficit in pharmaceutical products, which the Trump administration has suggested ...
Fierce Pharma10h
Following pharma's tariff trend, AbbVie unveils $10B US investment in 10 years
With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...
STAT10h
Vanderbilt medical center warns suppliers not to raise prices due to tariffs, or they may not get paid
Amid growing anxiety over tariffs, one medical center has warned its suppliers that any sudden price hikes attributed to the ...
STAT10h
Up and down the ladder: The latest comings and goings
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Exclusive: US pharma tariffs would raise US drug costs by $51 billion annually, report finds
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...
BioSpace11h
Fact or Fiction? Unpacking FDA Commissioner Marty Makary’s First Interviews
As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...
Fierce Biotech11h
M&A remains ‘top priority’ for Big Pharmas in the face of tariff threat
Big Pharmas aren’t letting the looming threat of potential tariffs divert them from their M&A strategies for the year—at ...
GV Wire11h
US Pharma Tariffs Would Raise US Drug Costs by $51 Billion Annually, Report Finds
Learn how a 25% Pharma tariff could raise U.S. drug costs by nearly $51 billion annually and impact prices significantly.